22
nunii Laboratoire
Commitments
Corporate Social Responsibility
About us
Careers
Legal Disclaimer
Dermatological Solutions
Skin concerns
Our Patented Technological Innovation
Product Range
The Science
Before and After Photos
News & Reviews
Media Coverage
Blog
Contact us
Personal data
© Nunii Laboratoire 2020
Bibliography:
1. Thierry Passeron, Mauro Picardo. “Melasma, a photo aging disorder”The official Journal of International Federation of Pigment Cell Societies- Society for Melanoma Research, Pigment Cell& Melanoma Research, Volume 31, Issue4, Pages 461-465.
2. Iiaria Muller and Aled Rees. “ Melasma and Endocrine Disorders. Journa of Pigmentary Disorders . S1:001. DOI 10.4172/2376-0427.S1-001.
3. Soon-Hyo Kwon, Young-Ji Hwang, Soo-Keun Lee, and Kyoung-Chan Park. “Heterogeneous Pathology of Melasma and Its Clinical Implications” Internationl Journal of Molecular Sciences. Published: 26 May 2016
4. Ai-Young Lee, Department of Dermatology, Dongguk University Ilsan Hospital, South Korea. “An updated review of melasma pathogenesis. DERMATOLOGICA SINICA 32 (2014) 233e239
Bibliography:
1. Abdel-Malek Z; Suzuki I; Tada A; Im S; Akacali C. The melanocortin-1 receptor and human pigmentation. Ann N Y Acad Sci. 199 Oct 20;885:117-33
2. Abdel-Malek Z; Scott MC; Suzuki I; Tada A; Im S; Lamoreux L; ito S; Barsh G; Hearing VJ. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation.. Pigment Cell Res. 2000;13 Suppl 8:156
3. Bertolotto C; Busca R; Ballotti R; Ortonne JP. L’AMP cyclique est un régulateur de la pigmentation de la peau.médecine/sciences 2001 ;17 :177-85
4. Buscà R1, Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 2000 Apr;13(2):60-9.
5. Cheli Y, Ohanna M, Ballotti R, Bertolotto C. Fifteen-year quest for microphtalmia-associated transcription factor target genes. Pigment Cell Melanoma Res. 2010 Feb;23(1):27-40.
6. Christina Wasmeier, Alistair N. Hume, Giulia Bolasco1 and Miguel C. Seabra. Melanosmes at a glance. Journal of Cell Science 2008;121,3995-3999
7. Corine Bertolotto, Karine Bille, Jean-Paul Ortonne, and Robert Ballotti. Regulation of Tyrosinase Gene Expression by cAMP in B16 Melanoma Cells Involves Two CATGTG Motifs Surrounding the TATA Box: Implication of the Microphthalmia Gene Product The Journal of Cell Biology, Volume 134, Number 3, August 1996 747-755.
8. Costin GE, Hearing VJ. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J. 2007;21:976–94. [PubMed]
9. Fistarol SK, Itin PH. Disorders of pigmentation. J DtschDermatolGes. 2010;8:187–201. [PubMed]
10. Jiri Vachtenheim1 and Jan Borovansky´ ‘‘Transcription physiology’’ of pigment formation in melanocytes: central role of MITF. Experimental Dermatology, 19, 617–627
11. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature. 2007;445:843–50. [PubMed]
12. Park HY, Kosmadaki M, Yaar M, Gilchrest BA. Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci. 2009;66:1493–506. [PubMed]
13. Plensdorf S, Martinez J. Common pigmentation disorders. Am Fam Physician. 2009;79:109–16. [PubMed]
14. Rouzaud F, Kadekaro AL, Abdel-Malek ZA, Hearing VJ. MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res. 2005;571:133–52. [PubMed]
15. Thody.AJ; Graham.A; Does alpha-MSH have a role in regulating skin pigmentation in humans?. Pigment Cell Res, 1998 Oct; 11(5):265-74.
16. Wang N1, Hebert DN. Tyrosinase maturation through the mammalian secretory pathway: bringing color to life. Pigment Cell Res. 2006 Feb;19(1):3-18.
17. Yamaguchi Y, Hearing VJ. Physiological factors that regulate skin pigmentation. Biofactors. 2009;35:193–[PMC free article] [PubMed]
18. Xufeng Wu, Blair Bowers, Kang Rao, Qin Wei, and John A. Hammer III. Visualization of Melanosome Dynamics within Wild-Type and Dilute Melanocytes Suggests a Paradigm for Myosin V Function In Vivo. The Journal of Cell Biology, Volume 143, Number 7, December 28, 1998 1899-1918
Bibliography:
1. En attente texte pour cette popup.
Bibliography:
1. Ortonne JP, Passeron T. Vitiligo and other disorders of hypopigmentation. In: Bolognia JL, Jorizzo JL, Schaffer JV, eds. Dermatology. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2012:chap 66.
2. Jazienicka Iwona, Katarzyna Kozlowicz, Anna Sokolowska, Jolanta Kwiatek. Phototoxic and photoallergic reactions after cosmetics: Department of Cosmetology and Aesthetic Medicine Medical University in Lublin Poland, Clinic and Department of Gynecology and Gynecologic Endocrinology Medical University in Lubin Poland.
3.CIR (Cosmetic Ingredient Review Expert Panel) Final report on the safety assessment of t-butyl hydroquinone. 1986.Journal of the American College of Toxicology 5, pp. 329–351.
4.Findlay, G. H., Morrison, J. G. L., & Simson, I. W. (1975). Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. British Journal of Dermatology, 93(6), 613-622.
5.Cardinali G, Kovacs D, Picardo M. Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo. Ann Dermatol Venereol. 2012 Dec;139 Suppl 4:S148-52. doi: 10.1016/S0151-9638(12)70127-8. Review. PubMed PMID: 23522630.
6. Lamel SA, Rahvar M, Maibach HI. Postinflammatory hyperpigmentation secondary to external insult: an overview of the quantitative analysis of pigmentation. Cutan Ocul Toxicol. 2013 Mar;32(1):67-71. doi: 10.3109/15569527.2012.684419. Epub 2012 Jun 6. Review. PubMed PMID: 22667459.
7. Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011 Apr 1;12(2):87-99. doi: 10.2165/11536930-000000000-00000. Review. PubMed PMID: 21348540
8. Davis EC, Callender VD; Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010 Jul 3(7):20-31.
9. Arora P, Sarkar R, Garg VK, et al; Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J Cutan Aesthet Surg. 2012 Apr 5(2):93-103. doi: 10.4103/0974-2077.99436.
10. Rossi AB, Leyden JJ, Pappert AS, et al; A pilot methodology study for the photographic assessment of post-inflammatory hyperpigmentation in patients treated with tretinoin. J Eur Acad Dermatol Venereol. 2011 Apr 25(4):398-402. doi: 10.1111/j.1468-3083.2010.03798.x.
11. Nestor M, Bucay V, Callender V, et al; Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders. J Clin Aesthet Dermatol. 2014 Mar 7(3):13-7.
Bibliography:
1. UVA & UVB, The Skin Cancer Foundation; Published on May 24, 2013 Medical Reviewers John H. Epstein, MD Stephen Q. Wang, MD.
2. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR 2007, Part Two-Chapter7, p244.
3. Artificial tanning devices: public health interventions to manage sunbeds. Geneva: World Health Organization; 2017, 2.1 p12
4. Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation / Robyn Lucas … [et al.] ; editors, Annette Prüss-Üstün … [et al.]. (Environmental burden of disease series ; no. 13.) World Health Organization 2006.
5. 11th Annual EWG sunscreen guide-Environmental working Group. http://www.ewg.org/sunscreen/report
6. Cosmetic Chemistry Paperback – Virtual Beauty Corporation November 1, 2009, Florence Barrett-Hill, ISBN-13: 978-0473124670 Chapter 1 Sun protection actives & Actions
